{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:06:21Z","timestamp":1790831181830,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Newgenpham Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.gie.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T22:36:56Z","timestamp":1582065416000},"page":"1044-1052.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial"],"prefix":"10.1016","volume":"92","author":[{"given":"Jong-chan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haeseong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaihwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyeok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2020.02.012_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gie.2020.02.012_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2020.02.012_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14701\/ahbps.2019.23.2.97","article-title":"Contemporary management of borderline resectable pancreatic ductal adenocarcinoma","volume":"23","author":"Lekka","year":"2019","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.gie.2020.02.012_bib4","doi-asserted-by":"crossref","first-page":"E976","DOI":"10.3390\/cancers11070976","article-title":"Locally advanced pancreatic cancer: work-up, staging, and local intervention strategies","volume":"11","author":"Van Veldhuisen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gie.2020.02.012_bib6","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","article-title":"Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Balaban","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gie.2020.02.012_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2017.03.022","article-title":"3rd St. Gallen EORTC Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of pancreatic cancer","volume":"79","author":"Lutz","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gie.2020.02.012_bib8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2018.08.008","article-title":"Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)","volume":"50","author":"Neuzillet","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gie.2020.02.012_bib9","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1118\/1.2349696","article-title":"The management of respiratory motion in radiation oncology report of AAPM Task Group 76","volume":"33","author":"Keall","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.gie.2020.02.012_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1118\/1.2426403","article-title":"Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions","volume":"34","author":"Spalding","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.gie.2020.02.012_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.22735","article-title":"Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy","volume":"110","author":"Krishnan","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.gie.2020.02.012_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s10434-001-0758-1","article-title":"Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas","volume":"8","author":"White","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gie.2020.02.012_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2006.12.053","article-title":"Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer","volume":"68","author":"Murphy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gie.2020.02.012_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.gt.3301398","article-title":"Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial","volume":"8","author":"Mulvihill","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib15","first-page":"2666","article-title":"Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53","volume":"60","author":"Dix","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.gie.2020.02.012_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.07.006","article-title":"Advances in oncolytic adenovirus therapy for pancreatic cancer","volume":"434","author":"Nattress","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gie.2020.02.012_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ymthe.2005.10.005","article-title":"Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity","volume":"13","author":"Barton","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/sj.mt.6300212","article-title":"Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer","volume":"15","author":"Freytag","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib19","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1158\/0008-5472.CAN-05-3033","article-title":"A\u00a0novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy","volume":"66","author":"Boucher","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.gie.2020.02.012_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association","volume":"270","author":"Al-Hawary","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.gie.2020.02.012_bib22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/mt.2008.172","article-title":"Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate","volume":"16","author":"Barton","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/mt.sj.6300120","article-title":"Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer","volume":"15","author":"Freytag","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gie.2020.02.012_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world's first oncolytic virus therapy for cancer treatment","volume":"98","author":"Garber","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.gie.2020.02.012_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.gie.2020.02.012_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/mt.2010.79","article-title":"Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth","volume":"18","author":"Guedan","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.gie.2020.02.012_bib30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510720301383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510720301383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:59:01Z","timestamp":1762163941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510720301383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0016510720301383"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2020.02.012","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Society for Gastrointestinal Endoscopy","name":"copyright","label":"Copyright"}]}}